Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Formoterol 6 mcg/Fluticasone 125 mcg (FORASMA) against Alenia 6 mcg/200 mcg in adults with moderate asthma; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alenia 6 mcg / 200 mcg
  • Formoterol 6 mcg / Fluticasone 125 mcg (FORASMA) combination inhaler (formoterol; fluticasone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Moderate Asthma | Phase 3 | Status: NOT_YET_RECRUITING